Pijnacker, Netherlands

Pieter Jan Burghout

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 7.8

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Pieter Jan Burghout

Introduction

Pieter Jan Burghout, hailing from Pijnacker, Netherlands, is a prominent inventor with a noteworthy portfolio of five patents. His work primarily centers around bioconjugation techniques that have significant implications in the field of pharmaceuticals and vaccine development.

Latest Patents

Burghout's latest inventions focus on the production of O18 bioconjugates. His patented methods involve host cells designed for creating a bioconjugate of an O18 antigen polysaccharide that is conjugated to a carrier protein. These host cells are distinguished by their modified Wzy O-antigen polymerases, which feature specific amino acid substitutions that enhance both the yield and glycosylation pattern of the produced bioconjugates. Another key patent relates to methods of producing bioconjugates of O-antigen polysaccharides that are covalently linked to a carrier protein, utilizing recombinant host cells that encode a specific oligosaccharyl transferase enzyme tailored for each O-antigen polysaccharide bioconjugate.

Career Highlights

Throughout his career, Pieter Jan Burghout has made significant contributions while working with esteemed organizations such as Janssen Pharmaceuticals, Inc. and GlaxoSmithKline Biologicals. His expertise in bioconjugation has positioned him as a valuable asset within the pharmaceutical industry, enhancing the potential for innovative vaccine solutions.

Collaborations

Burghout has collaborated with skilled colleagues, including Jeroen Geurtsen and Eveline Marleen Weerdenburg. These partnerships have fostered an environment of creativity and innovation, driving forward the development of cutting-edge biotechnological solutions.

Conclusion

Pieter Jan Burghout continues to make strides in the field of bioconjugation, leveraging his patents to contribute to advancements in vaccine technology. His work not only highlights his expertise but also underscores the importance of innovation in the ongoing fight against infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…